These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 11699060

  • 1. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL, Liang Y, Cincotta AH.
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [Abstract] [Full Text] [Related]

  • 2. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y, Lubkin M, Sheng H, Scislowski PW, Cincotta AH.
    Biochim Biophys Acta; 1998 Oct 21; 1405(1-3):1-13. PubMed ID: 9784590
    [Abstract] [Full Text] [Related]

  • 3. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W, Schott-Ohly P, Schulte im Walde S, Gleichmann H.
    Exp Clin Endocrinol Diabetes; 2004 Jan 21; 112(1):29-37. PubMed ID: 14758569
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat.
    Jörns A, Klempnauer J.
    Exp Clin Endocrinol Diabetes; 1995 Jan 21; 103 Suppl 2():103-6. PubMed ID: 8839264
    [Abstract] [Full Text] [Related]

  • 7. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?
    Chankiewitz E, Peschke D, Herberg L, Bazwinsky I, Mühlbauer E, Brömme HJ, Peschke E.
    Exp Clin Endocrinol Diabetes; 2006 May 21; 114(5):262-9. PubMed ID: 16804801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histological, immunocytochemical, and morphometrical analyses of pancreatic islets in the BSB mouse model of obesity.
    Slavin BG, Zarow C, Warden CH, Fisler JS.
    Anat Rec (Hoboken); 2010 Jan 21; 293(1):108-16. PubMed ID: 19798700
    [Abstract] [Full Text] [Related]

  • 10. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y, Cincotta AH.
    Int J Obes Relat Metab Disord; 2001 May 21; 25(5):698-704. PubMed ID: 11360153
    [Abstract] [Full Text] [Related]

  • 11. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.
    J Pharmacol Exp Ther; 2006 Aug 21; 318(2):914-21. PubMed ID: 16648370
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
    Wang Q, Brubaker PL.
    Diabetologia; 2002 Sep 21; 45(9):1263-73. PubMed ID: 12242459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice.
    Starich GH, Zafirova M, Jablenska R, Petkov P, Lardinois CK.
    Acta Histochem; 1991 Sep 21; 90(1):93-101. PubMed ID: 1675542
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.
    Duvillié B, Currie C, Chrones T, Bucchini D, Jami J, Joshi RL, Hill DJ.
    Endocrinology; 2002 Apr 21; 143(4):1530-7. PubMed ID: 11897712
    [Abstract] [Full Text] [Related]

  • 20. Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob/ob mice under basal conditions.
    Komori T, Morikawa Y, Tamura S, Doi A, Nanjo K, Senba E.
    Brain Res; 2005 Jul 05; 1049(1):34-42. PubMed ID: 15925330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.